We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$91.3B
AUM Growth
+$2.98B
(+3.4%)
Cap. Flow
-$825M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
34.96%
Holding
259
New
7
Increased
73
Reduced
140
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Airlines
UAL
|
+$144M |
| 2 |
Jacobs Solutions
J
|
+$83.6M |
| 3 |
CSX Corp
CSX
|
+$52.1M |
| 4 |
Ross Stores
ROST
|
+$51.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$47.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$218M |
| 2 |
Electronic Arts
EA
|
+$134M |
| 3 |
FedEx
FDX
|
+$124M |
| 4 |
Medtronic
MDT
|
+$120M |
| 5 |
Visa
V
|
+$83.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.32% |
| 2 | Healthcare | 25.97% |
| 3 | Industrials | 13.87% |
| 4 | Financials | 5.85% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMT
201
DELISTED
SMART TECHNOLOGIES INC COM NEW
SMT
| $13.7M | 0.02% |
479,825
-1,630
| -0.3% | -$55.9K |
|
|
CBI
202
DELISTED
Chicago Bridge & Iron Nv
CBI
| $13.5M | 0.01% |
197,600
| – | – |
|
203
Mercury Insurance
MCY
$6.03B
| $13.2M | 0.01% |
281,600
| – | – |
|
204
Cummins
CMI
$90.1B
| $12.8M | 0.01% |
83,150
| – | – |
|
205
Salesforce
CRM
$157B
| $11.9M | 0.01% |
204,160
+8,660
| +4% | +$468K |
|
206
Exelon
EXC
$46.7B
| $11.7M | 0.01% |
447,865
-140,200
| -24% | -$3.58M |
|
|
ESL
207
DELISTED
Esterline Technologies
ESL
| $11.3M | 0.01% |
98,431
+60,631
| +160% | +$6.69M |
|
|
KBIO
208
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $10.2M | 0.01% |
559,463
-26,971
| -5% | -$462K |
|
209
Oceaneering
OII
$4.86B
| $10.1M | 0.01% |
129,394
| – | – |
|
|
BRCD
210
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $9.2M | 0.01% |
1,000,000
-185,000
| -16% | -$1.7M |
|
|
CNR
211
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $8.55M | 0.01% |
440,000
+60,000
| +16% | +$1.02M |
|
|
ESV
212
DELISTED
Ensco Rowan plc
ESV
| $7.96M | 0.01% |
35,835
| – | – |
|
213
Thomson Reuters
TRI
$46.6B
| $7.27M | 0.01% |
172,339
| – | – |
|
214
Greif Class B
GEF.B
$4.24B
| $7.04M | 0.01% |
117,581
| – | – |
|
|
PNRA
215
DELISTED
Panera Bread Co
PNRA
| $7.02M | 0.01% |
46,875
| – | – |
|
216
NN Inc
NNBR
$295M
| $6.98M | 0.01% |
273,000
+216,926
| +387% | +$4.91M |
|
|
UTIW
217
DELISTED
UTI WORLDWIDE INC
UTIW
| $6.87M | 0.01% |
+664,000
| New | +$6.58M |
|
|
DNDN
218
DELISTED
DENDREON CORPORATION
DNDN
| $6.67M | 0.01% |
2,901,800
-167,900
| -5% | -$394K |
|
|
CRDC
219
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $6.66M | 0.01% |
584,270
+324,310
| +125% | +$3.29M |
|
220
TransDigm Group
TDG
$69.7B
| $6.39M | 0.01% |
38,200
| – | – |
|
221
Petrobras
PBR
$119B
| $6.29M | 0.01% |
430,000
| – | – |
|
|
OMED
222
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $6.21M | 0.01% |
266,400
-74,300
| -22% | -$1.83M |
|
223
Arista Networks
ANET
$249B
| $6.17M | 0.01% |
+1,582,400
| New | +$6.36M |
|
224
Enovis
ENOV
$1.77B
| $5.4M | 0.01% |
42,123
-5,287
| -11% | -$660K |
|
225
Agilent Technologies
A
$39.7B
| $5.27M | 0.01% |
128,220
-3,205
| -2% | -$129K |
|
Similar funds
VAM
Primecap Management's Q2 2014 Portfolio in Review
As of Q2 2014, Primecap Management held 259 positions worth $91.3B, up 3.4% from $88.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Trading was light in Q2 2014: portfolio turnover was 4.6%. Primecap Management opened 7 new positions and exited 5, leaving the 259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2014 buy was Exact Sciences: 2,491,300 shares worth $42.4M.
- Primecap Management added most to United Airlines in Q2 2014, an estimated $144M increase.
- Primecap Management's biggest Q2 2014 reduction was GSK, cutting an estimated $218M.
- Primecap Management fully exited Akamai in Q2 2014, selling an estimated $4.77M.
- Primecap Management's ten largest holdings make up 35% of its $91.3B portfolio in Q2 2014.
- Primecap Management opened 7 new positions and closed 5 in Q2 2014.
- Primecap Management's portfolio value rose 3.4% quarter-over-quarter to $91.3B.
Based on Primecap Management's 13F filing for Q2 2014, filed 14 Aug 2014.